✦ LIBER ✦

Tyrosine-kinetics in hepatic and renal failure

✍ Scribed by W. Drumi; M. Fischer; E. Roth; H. Lochs

Book ID: 119149106
Publisher: Elsevier Science
Year: 1994
Tongue: English
Weight: 132 KB
Volume: 13
Category: Article
ISSN: 0261-5614
DOI: 10.1016/0261-5614(94)90187-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Renal failure in hepatic failure

✍ V. P. Choudhry; M. K. Bhan 📂 Article 📅 1980 🏛 Springer-Verlag 🌐 English ⚖ 297 KB

Bumetanide kinetics in renal failure

✍ Pentikäinen, Pertti J; Pasternack, Amos; Lampainen, Erkki; Neuvonen, Pertti J; P 📂 Article 📅 1985 🏛 Nature Publishing Group 🌐 English ⚖ 369 KB

Atenolol kinetics in renal failure

✍ McAinsh, J; Holmes, B F; Smith, S; Hood, D; Warren, David 📂 Article 📅 1980 🏛 Nature Publishing Group 🌐 English ⚖ 381 KB

Viral hepatitis and renal failure

✍ Elsa Marisol Pichardo; Sonja Olsen; Robert S. Brown 📂 Article 📅 2009 🏛 Current Science Inc. 🌐 English ⚖ 335 KB

Hepatitis C and renal failure

✍ Robert L Carithers Jr. 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 72 KB

Utilization of tyrosine-containing dipep

Utilization of tyrosine-containing dipeptides and N-acetyl-tyrosine in hepatic failure

✍ Wilfred Druml; Wolfgang Hübl; Erich Roth; Herbert Lochs 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 674 KB

The impact of hepatic dysfunction on the elimination and hydrolysis of three potential tyrosine sources for total parenteral nutrition, the dipeptides L-alanyl-L-tyrosine (Ala-Tyr) and glycyl-L-tyrosine (Gly-Tyr), and Nacetyl-L-tyrosine (Nac-Tyrf were evaluated in six patients with hepatic failure (